Related by context. Frequent words. (Click for all words.) 61 hematological malignancies 58 Phase Ib 57 ofatumumab 57 HspE7 57 XL# [003] 57 perifosine 55 MGCD# [001] 55 investigational compound 54 Phase 1b 54 MGCD# [002] 54 AP# [003] 54 dose escalation 54 T DM1 54 voreloxin 53 carfilzomib 53 CUDC 53 oncology indications 53 FOLOTYN 53 Phase 2b trial 53 humanized monoclonal antibody 53 hematologic malignancies 53 dose escalation study 52 antitumor activity 52 IMGN# 52 carboplatin 52 preclinical 52 solid tumors 52 Phase IIa clinical 52 kinase inhibitor 52 RDEA# 52 Phase 2b study 51 AEZS 51 bortezomib 51 Phase 2a 51 RG# [001] 51 tivozanib 51 ENMD 51 Phase IIa trial 51 ARRY 50 NKTR 50 Phase 2b clinical 50 advanced NSCLC 50 AZD# 50 Preclinical studies 50 CRx 50 Phase III clinical 50 Phase IIb 50 docetaxel 50 NSCLC 50 Phase 2a clinical 50 PRX # 50 epratuzumab 50 CYT# 50 ALKS 49 ASA# 49 APD# 49 pivotal Phase III 49 gemcitabine 49 APF# 49 MDV# 49 Phase 2b 49 preclinical studies 49 IDX# 49 investigational drug 49 REOLYSIN 49 monotherapy 49 picoplatin 49 Phase IIb clinical 49 pharmacodynamic 49 LymphoStat B 49 INCB# [002] 49 ISIS # 49 daclizumab 48 Phase III 48 linaclotide 48 Phase II 48 pivotal Phase 48 taxane 48 elesclomol 48 ARQ 48 randomized Phase 47 hepatocellular carcinoma 47 metastatic colorectal cancer 47 Tovaxin 47 RNAi therapeutic 47 anticancer agents 47 Phase IIb trial 47 CK # 47 bavituximab 47 satraplatin 47 PLX# 46 laquinimod 46 preclinical models 46 gefitinib 46 Marqibo 46 ITMN 46 tolerability profile 46 metastatic melanoma 46 temozolomide 46 Phase IIa 46 CBLB#